INSP - CIK 0001609550
Inspire Medical Systems, Inc. (INSP) reported revenue of $911.98M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $911.98M | +13.6% |
| FY 2024 | $802.80M | +28.5% |
| FY 2023 | $624.80M | +53.2% |
| FY 2022 | $407.86M | +74.7% |
| FY 2021 | $233.39M | +102.3% |
| FY 2020 | $115.38M | +40.6% |
| FY 2019 | $82.05M | +62.2% |
| FY 2018 | $50.59M | +77.1% |
| FY 2017 |
Inspire Medical Systems, Inc. (INSP) reported revenue of $911.98M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2016 and fiscal 2025, Inspire Medical Systems, Inc.'s revenue grew from $16.43M to $911.98M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $28.57M |
| +73.9% |
| FY 2016 | $16.43M | - |